All UK & Rest of Europe articles – Page 36
-
NewsStudies probe how novel inhibitors can switch efflux pumps off in TB bacteria
Two new studies aim to both identify and understand how novel inhibitors can switch efflux pumps off in the bacteria Mycobacterium tuberculosis.
-
NewsGlobal phage experts converge in Berlin to shape the future of antimicrobial medicine
The 8th World Congress on Targeting Phage Therapy (June 10–11, 2025) returns to Berlin, bringing together over 75 international speakers and contributors from 27 countries.
-
NewsMum’s obesity linked to child’s heightened hospital admission risk for infection
Children born to mothers who are very obese with a BMI of 35 or higher are at heightened risk of being admitted to hospital for an infection, finds a long term study.
-
NewsSmart plastics are key to curbing healthcare infection rates, says Symphony Environmental
A leading plastics innovator urges hospitals and care-homes to adopt antimicrobial smart plastic solutions to address infection rates.
-
NewsNitrogen loss on sandy shores: The big impact of tiny anoxic pockets
Denitrification in tiny anoxic pockets on sand grains could account for up to one-third of total nitrogen loss in silicate shelf sands, a new study reveals.
-
NewsMultiple testing for infectious diseases among migrants key to cutting onward transmission
Routine testing for multiple infectious diseases among migrants will benefit healthcare systems by identifying key infections earlier, a new study finds.
-
NewsLavender and lemongrass oils effective against thrush infections, new research reveals
They may be more familiar as a room scent but a new study being presented at the Letters in Applied Microbiology ECS Research Symposium 2025 reveals that lavender and lemongrass essential oils are effective against thrush, even at low levels.
-
NewsAfrican swine fever not recently imported to Europe, has been around for years
A new study finds that the African Swine Fever virus, currently circulating in Europe, is not the result of a recent introduction. Instead, the virus has been present in the region since 2007.
-
NewsSynthetic compound shows promise against multidrug resistance
Researchers have synthesized a new compound called infuzide that shows activity against resistant strains of pathogens. In lab and mouse tests, infuzide reduced bacterial populations, suggesting it might be useful as a new treatment for drug-resistant infections.
-
NewsNew study reveals bats are key players in cross-species spread of morbilliviruses
Researchers studying the spread of morbilliviruses in bats and monkeys in Brazil and Costa Rica have discovered new virus species and host switches from bats to other mammalian species.
-
NewsTargeting malaria parasite’s protein control system could be key to innovative treatments
By inducing protein aggregation in Plasmodium falciparum, researchers have observed considerable disorders in protein homeostasis and a significant reduction in parasite growth.
-
NewsNew microscope harnesses bioluminescence to bring glowing cells into focus
Researchers have developed a new microscope that significantly improves how bioluminescent signals in living cells can be observed. The system, known as QIScope, is built around a highly sensitive camera technology capable of detecting extremely low levels of light.
-
NewsUncovered: A long-lasting history of leprosy in the Americas
A new study challenges the view that leprosy is a disease that was introduced into the Americas during European colonization. A strain of leprosy-causing mycobacterium, Mycobacterium lepromatosis, infected humans in the Americas before European contact.
-
NewsHow the plague bacillus became less virulent, prolonging the duration of two major pandemics
Scientists have discovered that the evolution of a gene in the bacterium that causes bubonic plague, Yersinia pestis, may have prolonged the duration of two major pandemics. Modifying the copy number of a specific virulence gene increases the length of infection.
-
NewsGut bacteria may hold key to unlocking better cancer treatment
Scientists have discovered a range of microbial ‘biomarkers’ that could help to improve detection and treatment of gastrointestinal diseases (GIDs) such as gastric cancer (GC), colorectal cancer (CRC), and inflammatory bowel disease (IBD).
-
NewsYeast produces human DNase1 for the first time
The protein DNase1 is used to treat cystic fibrosis but it takes considerable effort and cost to produce it in immortalized hamster cells. Researchers have now produced it in yeast cells for the first time.
-
NewsIntestinal bacteria influence aging of blood vessels
Researchers have shown for the first time that intestinal bacteria and their metabolites can accelerate the ageing of blood vessels and trigger cardiovascular disease.
-
NewsOral microbiota transmission partially mediates depression and anxiety in newlywed couples
Given that bacterial transmission can occur between spouses, a new study aimed to investigate whether the transmission of oral microbiota between newlywed couples mediates symptoms of depression and anxiety.
-
NewsUsing bacteria to improve microbiota resistance to pathogens
A new study aimed to identify the bacteria involved in the barrier effect shown by microbiota and prove their effectiveness in preventing the proliferation of pathogenic bacteria, with a view to developing a therapeutic strategy.
-
NewsPortable HIV monitoring device shows promise for remote settings
A newly developed microfluidic biosensor promises to reshape how CD4+ T cells — key indicators of immune function in Human Immunodeficiency Virus (HIV) patients — are detected.